Table 2.
Rotavirus VE for ≥1 and 2 doses in preventing hospitalization due to AGE and RVGE in vaccinated children compared to unvaccinated children from the post-universal vaccination period.
| Hospitalized | Total | Proportion (%) | Crude VE [95% CI], % | Adjusted VEa [95% CI], % | |
|---|---|---|---|---|---|
| ≥1 dose | |||||
| AGE | |||||
| Vaccinated | 28 | 5,033 | 0.56 | ||
| Unvaccinated | 11 | 1,239 | 0.89 | 38 [−26 to 69] | 23 [−58 to 63] |
| RVGE | |||||
| Vaccinated | 2 | 5,033 | 0.04 | ||
| Unvaccinated | 1 | 1,239 | 0.08 | 51 [−443 to 96] | NAb |
| 2 doses | |||||
| AGE | |||||
| Vaccinated | 20 | 4,767 | 0.42 | ||
| Unvaccinated | 11 | 1,239 | 0.89 | 53 [2 to 78] | 41 [−27 to 73] |
| RVGE | |||||
| Vaccinated | 1 | 4,767 | 0.02 | ||
| Unvaccinated | 1 | 1,239 | 0.08 | 74 [−316 to 98] | NAb |
a
Adjusted for sex, maternal age at birth, prematurity and age at the end of the study in months.
b
Multivariate analyses could not be performed because of the small number of cases in post-program period.
NA indicates non applicable.